CD163 and neoplasm: To further study the potential clinical relevance of PLXDC2 expression in tumor progression, we made use of 67 TMA with adequate PLXDC2 and CD163 staining effect of GC patient samples to compare the expression of PLXDC2 between GC tumor tissues and stromal tissues.